JB Chemicals Net Plunges 76 Percent in Jun'07 Qtr (India)
This article was originally published in PharmAsia News
Globally powerful India-based pharmaceutical company JB Chemicals & Pharmaceuticals posted a 76.40 percent net profit decline during second-quarter 2007 ending on June 30 compared to second-quarter 2006. The company's second quarter net sales rose by 4.07 percent, however, while its declining profit still came in at a positive RS 30.71 million crore. This company has worldwide distribution in over 50 countries. Its earnings per share registered at RS 0.36 in second-quarter 2007 compared to RS 1.55 during the same period last year. (Click here for more
You may also be interested in...
Circassia is returning the US rights to two COPD drugs to AstraZeneca as it admits it cannot meet its debt payments from the deal.
At their second meeting on COVID-19, drug regulators from around the world have stressed the importance of large, multi-arm studies in generating the data needed for the approval of potential coronavirus therapies. The European Medicines Agency, which organized the meeting, has also announced a new coronavirus task force to identify promising drug candidates and help steer them through development to regulatory approval.